UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Seminars in nephrology, ISSN 0270-9295, 2016, Volume 36, Issue 6, pp. 436 - 447
Nephrology | Diabetic nephropathy | renal outcomes | SGTL2 | inflammation | Angiotensin | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Hypoglycemic Agents - therapeutic use | Oxidative Stress | Glycosaminoglycans - therapeutic use | Humans | Oleanolic Acid - analogs & derivatives | Diabetic Nephropathies - drug therapy | Sodium-Glucose Transporter 2 Inhibitors | Pyridoxamine - analogs & derivatives | Atrasentan | Drug Discovery | Mineralocorticoid Receptor Antagonists - therapeutic use | Pyrrolidines - therapeutic use | Renal Insufficiency, Chronic - drug therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Canagliflozin - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Glucosides - therapeutic use | Oleanolic Acid - therapeutic use | Endothelin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Benzhydryl Compounds - therapeutic use | Pyridoxamine - therapeutic use | Index Medicus | Please provide
Journal Article
Diabetes care, ISSN 0149-5992, 09/2013, Volume 36, Issue 9, pp. 2508 - 2515
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - therapeutic use | Thiophenes - therapeutic use | Metformin - therapeutic use | Double-Blind Method | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Sulfonylurea Compounds - therapeutic use | Male | Treatment Outcome | Pyrazines - therapeutic use | Blood Glucose - drug effects | Canagliflozin | Female | Glucosides - therapeutic use | Aged | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Triazoles - therapeutic use | Type 2 diabetes | Glucose metabolism | Care and treatment | Blood cholesterol | Hypoglycemic agents | Glucose | Pharmaceutical industry | Comparative analysis | Dextrose | Diabetes therapy | Side effects | Clinical trials | Diabetes | Hypoglycemia | Drug therapy | Weight | Index Medicus | Original Research
Journal Article
Endocrine practice, ISSN 1530-891X, 07/2017, Volume 23, Issue 7, pp. 831 - 840
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Dipeptides - therapeutic use | Metformin - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Uracil - therapeutic use | Treatment Outcome | Linagliptin - therapeutic use | Diabetes Mellitus, Type 2 - metabolism | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Canagliflozin - therapeutic use | Piperidines - therapeutic use | Adamantane - therapeutic use | Sitagliptin Phosphate - therapeutic use | Glucosides - therapeutic use | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Hypoglycemia - chemically induced | Benzhydryl Compounds - therapeutic use | Adamantane - analogs & derivatives | Uracil - analogs & derivatives
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 07/2017, Volume 56, Issue 7, pp. 703 - 718
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Canagliflozin - pharmacokinetics | Dipeptides - therapeutic use | Dipeptides - pharmacokinetics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Linagliptin - pharmacokinetics | Treatment Outcome | Glucosides - pharmacokinetics | Linagliptin - therapeutic use | Diabetes Mellitus, Type 2 - metabolism | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics | Canagliflozin - therapeutic use | Adamantane - therapeutic use | Sitagliptin Phosphate - therapeutic use | Glucosides - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Adamantane - pharmacokinetics | Benzhydryl Compounds - pharmacokinetics | Sitagliptin Phosphate - pharmacokinetics | Adamantane - analogs & derivatives
Journal Article
Diabetes care, ISSN 0149-5992, 01/2018, Volume 41, Issue 1, pp. 6 - 10
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Follow-Up Studies | Bias | Diabetes Mellitus, Type 2 - genetics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Mortality | Risk Factors | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - epidemiology | Randomized Controlled Trials as Topic | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Observational Studies as Topic | Glucosides - therapeutic use | Benzhydryl Compounds - therapeutic use | Insulin - therapeutic use | Cohort Studies | Health care | Drugs | Uncertainty | Peptidase | Diabetes mellitus | Health risks | Clinical trials | Risk | Glucose | Insulin | Patients | Prescription drugs | Inhibitors | Sodium | Death | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Index Medicus
Journal Article
Annual review of medicine, ISSN 0066-4219, 1/2015, Volume 66, Issue 1, pp. 255 - 270
body weight | sodium-glucose cotransporter | glucose reabsorption | glomerular hyperfiltration | hypertension | gluconeogenesis | diabetic nephropathy | Hypoglycemic Agents - therapeutic use | Thiophenes - therapeutic use | Sodium-Glucose Transporter 2 - metabolism | Humans | Diabetes Mellitus, Type 1 - metabolism | Diabetes Mellitus, Type 2 - metabolism | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Diabetes Mellitus, Type 1 - drug therapy | Kidney - metabolism | Canagliflozin | Glucosides - therapeutic use | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Glucose metabolism | Health aspects | Methods | Diabetes therapy | Hyperglycemia | Blood pressure | Inhibitor drugs | Diabetes | Glucose | Hypoglycemia | Index Medicus
Journal Article
Diabetes & metabolism, ISSN 1262-3636, 12/2018, Volume 44, Issue 6, pp. 493 - 499
Type 2 diabetes | Alanine aminotransferase | Antihyperglycaemic agents | Non-alcoholic fatty liver disease | SGLT2 inhibitors | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Humans | Middle Aged | Male | Treatment Outcome | Alanine Transaminase - blood | Canada | Diabetes Mellitus, Type 2 - blood | Canagliflozin - therapeutic use | Liraglutide - therapeutic use | Aged, 80 and over | Sitagliptin Phosphate - therapeutic use | Female | Glucosides - therapeutic use | Registries | Aged | Retrospective Studies | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Index Medicus
Journal Article
BMJ open, ISSN 2044-6055, 02/2016, Volume 6, Issue 2, pp. e009417 - e009417
Hypoglycemic Agents - therapeutic use | Metformin - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Sodium-Glucose Transporter 2 Inhibitors | Weight Loss - drug effects | Diabetes Mellitus, Type 2 - blood | Sorbitol - analogs & derivatives | Canagliflozin - therapeutic use | Bayes Theorem | Glucosides - therapeutic use | Blood Pressure - drug effects | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Sorbitol - therapeutic use | Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 01/2015, Volume 75, Issue 1, pp. 33 - 59
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Thiophenes - therapeutic use | Glucosides - pharmacology | Thiophenes - adverse effects | Humans | Thiophenes - pharmacology | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Hypoglycemic Agents - pharmacology | Benzhydryl Compounds - adverse effects | Canagliflozin | Glucosides - therapeutic use | Benzhydryl Compounds - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Hypoglycemic Agents - adverse effects | Glucosides - adverse effects
Journal Article